[Form 4] Bausch Health Companies Inc Insider Trading Activity
John Paulson, a director and the controlling person of Paulson Capital Inc., reported purchases of Bausch Health Companies common stock executed by funds he manages. The filings show three purchases: 2,000,000 shares at $6.35, 1,156,640 shares at $6.88, and 86,409 shares at $7.06, totaling 3,243,049 shares. After these transactions the reporting person’s indirect beneficial ownership is stated as 36,034,751 shares. The shares are held by managed funds and the report includes a disclaimer that the reporting person disclaims beneficial ownership except to the extent of any pecuniary interest. No derivative securities were reported on the form.
- Managed funds acquired a total of 3,243,049 BHC shares across three purchases.
- Purchases executed at prices between $6.35 and $7.06, indicating active accumulation over consecutive days.
- Reported indirect holdings increased to 36,034,751 shares, providing clear post-transaction ownership figures.
- Holdings are reported as indirect by managed funds, and the reporting person disclaims beneficial ownership except to the extent of any pecuniary interest.
- No derivative securities were reported, so there is no disclosed options or other instruments to amplify exposure.
Insights
Director-managed funds added 3.24M BHC shares, raising indirect holdings to 36.03M — a substantial accumulation by Paulson-managed vehicles.
The transactions consist of three purchases executed on consecutive days, totaling 3,243,049 shares at prices between $6.35 and $7.06. These purchases were reported as indirect holdings by funds managed by John Paulson, increasing the reported indirect stake to 36,034,751 shares. The Form 4 shows purchases only (transaction code 'P') and no derivative activity. From a market perspective, concentrated purchases by a prominent investment manager are material signals; the filing documents compliance with Section 16 reporting and includes a standard disclaimer about beneficial ownership.
Substantial purchases were made via managed funds, but the reporting person disclaims beneficial ownership, limiting direct disclosure of personal economic exposure.
The filing identifies John Paulson as a director and the investment manager of the funds that directly own the shares. It explicitly states that ownership is indirect (I) and includes the customary disclaimer under Rule 16a-1(a)(4) that the reporting person disclaims beneficial ownership except for any pecuniary interest. The Form was filed by one reporting person and documents only non-derivative purchases. From a governance standpoint, the indirect nature of the holdings and the disclaimer are important for understanding how much of the position is attributable to managed vehicles versus personal ownership.